Results 61 to 70 of about 131 (72)

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes

Nature, 2018
Thomas Engleitner, Roman Maresch, Sebastian Lange   +2 more
exaly  

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo

Nature Medicine, 2018
Giovanni Germano, Jeffrey D Steinberg, Niels de Wit   +2 more
exaly  

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Nature Reviews Clinical Oncology, 2009
Nicola Normanno, Floriana Morgillo, Antonella De Luca   +2 more
exaly  

A combinatorial strategy for treating KRAS-mutant lung cancer

Nature, 2016
Eusebio Manchado, Chi-Chao Chen, Amaia Lujambio   +2 more
exaly  

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Nature Medicine, 2018
Jin Zhou, Zhong Wu, Steven E Schumacher
exaly  

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Cancer Cell, 2019
Wen-Ting Liao, Michael J Overman, Di Zhao   +2 more
exaly  

KRAS4A directly regulates hexokinase 1

Nature, 2019
Seth J Parker, Helen Court, Eli Rothenberg   +2 more
exaly  

Contact karst of Southern Velebit (Croatia): Kontaktni kras južnega Velebita (Hrvaška):

2001
Buzjak, Nenad, Perica, Dražen
openaire   +1 more source

Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism

Science, 2016
Piro Lito, Lian-Sheng Li, Neal Rosen
exaly  

Contact karst of Brkini Hills: Brkinski kontaktni kras:

1994
openaire   +1 more source